Immix Biopharma Inc
Stock Chart, Company Information, and Scan Results
$8.68(as of Jul 27, 3:59 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Immix Biopharma Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$8.68
Ticker SymbolIMMX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees21
CountyUSA
Market Cap$606.5M
EBIDTA-35.8M
P/E Ratio0.00
Forward P/E Ratio0.00
Earnings per Share-0.92
Profit Margin0.00%
RSI41.17
Shares Outstanding71.2M
ATR0.83
52-Week High12.14
Volume1,970,341
52-Week Low1.94
Book Value0.0M
P/B Ratio0.00
Upper Keltner11.99
P/S Ratio0.00
Lower Keltner8.26
Next Earnings Date08/14/2026
Cash Surplus0.0M
Next Ex-Dividend DateUnknown
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.
Immix Biopharma Inc In Our Stock Scanner
As of Jul 27, 2026
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---
Scan Name: Double BottomScan Type: Chart Pattern Scans
As of ---
Scan Name: Doji CandlesScan Type: Candlestick Pattern Scans
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.